Bioshell Oral Antiseptic
NDC Package 66357-030-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Bioshell Oral Antiseptic is a . Marketed by Biofilm Inc, this product is identified by NDC 66357-030 and is authorized under FDA application part356.

Identification & Billing

NDC Package Code
66357-030-01
Package Description
1 BOTTLE, DISPENSING in 1 CARTON / 30 mL in 1 BOTTLE, DISPENSING
Product Code
66357-030
11-Digit Billing Format
66357003001

Clinical Specifications

Proprietary Name
Bioshell Oral Antiseptic
Dosage Form
-

Regulatory & Marketing

Labeler Name
Biofilm Inc
FDA Application #
part356
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
03-17-2022
End Marketing Date
05-04-2022
Listing Expiration
05-04-2022
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66357-030-01 identifies a specific commercial package of 1 bottle, dispensing in 1 carton / 30 ml in 1 bottle, dispensing of Bioshell Oral Antiseptic, labeled by Biofilm Inc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Biofilm Inc on March 17, 2022. The current certification is valid through May 04, 2022.

How is this Biofilm Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66357003001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
66357-030-01
11-Digit CMS (5-4-2)
66357-0030-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.